|Articles|May 1, 2018
- Pharmaceutical Executive-05-01-2018
- Volume 38
- Issue 5
Pharmaceutical Executive, May 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Brands of the Year: Promise and Challengeabout 8 years ago
Gauging the Collaborative Spirit in European Healthabout 8 years ago
Gottlieb Tackles Drug Competition & Costsabout 8 years ago
Deploying the Cloud in GxP Environmentsabout 8 years ago
So Much Depends on the Physicianabout 8 years ago
Bridging Science & Strategy: An Investor’s Eyeabout 8 years ago
Patient Empowerment and the Future of Pharma Advertisingabout 8 years ago
Closing Pharma’s Digital Divideabout 8 years ago
Patient KOLs: Their Guide to Entering Crowded Marketsabout 8 years ago
The Total Care PackageAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising, Alleging Misleading Dosing Comparisons
3
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
4
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
5